Basis: FMP quote market capitalization / book value attributable to common shareholders (matching reported total stockholders equity minus preferred stock). Source: stored company filings and market data; unavailable inputs remain N/A.
The P/B ratio is N/A as of 2026-10-06T21:33:00.870Z.
Calculation as of: 2026-10-06T21:33:00.870Z.
Quote observation: 2026-10-05T20:00:00.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 0fde8dae4c5ae63ee7b35c7e6e46bba2fdf5d6d5db310b32cf0eb41a7e17e840
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
PB RATIO
N/A
Market Cap
$548.51M
PB Ratio
N/A
TTM Avg
31.55
3Y Avg
10.90
5Y Avg
9.66
Market Cap
$578.40M
PB Ratio
N/A
TTM Avg
10.63
3Y Avg
10.63
5Y Avg
10.63
Market Cap
$533.04M
PB Ratio
4.07
TTM Avg
5.24
3Y Avg
14.72
5Y Avg
12.64
| NAME | MARKET CAP | PB RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| MiniMed Group, Inc. (MMEDV) | $560.00M | N/A | N/A | N/A | N/A |
| CytomX Therapeutics, Inc. (CTMX)vs › | $557.32M | 1.85 | 4.83 | 5.15 | 4.11 |
| CorMedix Inc. (CRMD)vs › | $571.13M | 1.24 | 2.02 | 4.79 | 4.03 |
| Phathom Pharmaceuticals, Inc. (PHAT)vs › | $548.51M | N/A | 31.55 | 10.90 | 9.66 |
| Aquestive Therapeutics, Inc. (AQST)vs › | $578.40M | N/A | 10.63 | 10.63 | 10.63 |
| ProKidney Corp. (PROK)vs › | $538.01M | N/A | 39.00 | 39.00 | 39.00 |
| OrthoPediatrics Corp. (KIDS)vs › | $583.31M | 1.70 | 1.28 | 1.52 | 2.34 |
| Fulgent Genetics, Inc. (FLGT)vs › | $584.48M | 0.58 | 0.59 | 0.57 | 0.87 |
| Monopar Therapeutics Inc. (MNPR)vs › | $533.04M | 4.07 | 5.24 | 14.72 | 12.64 |
| Delcath Systems, Inc. (DCTH)vs › | $531.98M | 4.39 | 3.92 | 15.48 | 13.15 |
P/B Ratio
N/A
Market Price / Book Value per Share
PB Ratio = Market Cap / (Total Shareholders' Equity − Preferred Stock)
The price-to-book ratio compares market capitalization to book value attributable to common shareholders (total equity minus preferred stock). Lower values can indicate a cheaper valuation relative to net assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
